Related Experiment Videos
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Yong Zhang1, Xinsheng Gao, Leslie J Saucedo
1Department of Physiology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9040, USA.
Abstract:
Mutations in the TSC1 or TSC2 genes cause tuberous sclerosis, a benign tumour syndrome in humans. Tsc2 possesses a domain that shares homology with the GTPase-activating protein (GAP) domain of Rap1-GAP, suggesting that a GTPase might be the physiological target of Tsc2. Here we show that the small GTPase Rheb (Ras homologue enriched in brain) is a direct target of Tsc2 GAP activity both in vivo and in vitro. Point mutations in the GAP domain of Tsc2 disrupted its ability to regulate Rheb without affecting the ability of Tsc2 to form a complex with Tsc1. Our studies identify Rheb as a molecular target of the TSC tumour suppressors.
Insights
Mutations in TSC1 or TSC2 genes cause tuberous sclerosis. This study identifies Rheb (Ras homologue enriched in brain) as a direct target of Tsc2 GTPase-activating protein (GAP) activity, revealing a key molecular mechanism.
Area of Science:
- Molecular biology
- Genetics
- Biochemistry
Background:
- Tuberous sclerosis is a benign tumor syndrome caused by mutations in TSC1 or TSC2 genes.
- Tsc2 protein contains a domain homologous to GTPase-activating protein (GAP) domains, suggesting a GTPase as its physiological target.
Purpose of the Study:
- To identify the direct molecular target of Tsc2's GTPase-activating protein (GAP) activity.
- To elucidate the role of Rheb (Ras homologue enriched in brain) in the TSC tumor suppressor pathway.
Main Methods:
- In vivo and in vitro assays were used to investigate the interaction between Tsc2 and Rheb.
- Site-directed mutagenesis was employed to study the function of the Tsc2 GAP domain.
Main Results:
- Rheb was identified as a direct target of Tsc2 GAP activity.
- Mutations in the Tsc2 GAP domain impaired Rheb regulation but not Tsc1 complex formation.
Conclusions:
- Rheb is a direct molecular target of the TSC tumor suppressor complex.
- This finding provides a mechanistic link between TSC gene mutations and tumor development.